In healthcare, "profitable" is a taboo word. However, if it is not profitable, it is not sustainable
In Conversation
Merck’s heritage in Spain is a heritage of innovation and the company has chosen to build on that historic presence
We utilised a conceptual decision-making framework [to respond to COVID-19]; economy and health are not opposing terms, they are complimentary. Our goal was to boost economic…
Ultimately, CataloniaBio & HealthTech wishes to position Catalonia as one of the top health hubs in the world
The Spanish ecosystem knows the recipe and understands that there must be a permanent dialogue between the administration, patients, HCPs, academia, regulatory authorities, and industry
Four years ago, a molecule discovered and designed by scientists in Alcobendas for the treatment of metastatic breast cancer was approved by regulatory agencies across the…
I hope that the COVID-19 pandemic has foregrounded the value that [the generics] industry can bring
Spanish biotechnology is very strong and internationally competitive in many fields, including among others biocatalysis, nanobiotechnology, microbial biotechnology and cancer research
The main reason for the company’s financial success is our driven and loyal workforce which has gone above and beyond during the COVID-19 crisis, in addition…
The main challenge for orphan drugs in Spain is access, which has become highly complex in recent years
Plasma-derived therapies are unique life-saving treatments based on a very special and finite raw material, therefore regulations should take this into account
mAbxience has a different business model than the majority of big biosimilars producers which have vast sales and marketing capabilities. We have a business-to-business (B2B) model,…
